ICD-10-CM Coding for BPH with Bladder Outlet Obstruction and Urinary Retention
For a 57-year-old man with lower abdominal pain relieved by urination due to bladder outlet obstruction from benign prostatic hyperplasia, use N40.1 (Benign prostatic hyperplasia with lower urinary tract symptoms) as the primary code, and add R33.8 (Other retention of urine) or R33.9 (Retention of urine, unspecified) as a secondary code if urinary retention is documented.
Primary Diagnosis Code
The primary code should capture the underlying pathology:
- N40.1: Benign prostatic hyperplasia with lower urinary tract symptoms (LUTS)
Secondary Code for Urinary Retention
Yes, a secondary code for urinary retention should be added if documented:
- R33.8: Other retention of urine (if specific type documented)
- R33.9: Retention of urine, unspecified (if retention present but not further specified)
The secondary code is warranted because:
- Urinary retention is a distinct complication of BPH-related bladder outlet obstruction 3, 4
- It represents a significant clinical finding that affects treatment decisions and prognosis
- Retention can be acute or chronic; if post-void residual (PVR) volume >300 mL on two separate occasions persisting ≥6 months, this constitutes chronic retention 4
Clinical Context for Coding
The patient's presentation suggests:
- Bladder outlet obstruction from prostatic enlargement causing incomplete emptying
- Pain with bladder distension that resolves after voiding indicates obstructive pathophysiology
- This pattern is consistent with BPH causing both voiding dysfunction and potential retention 5, 2
Common Coding Pitfalls
- Don't use N40.0 (BPH without LUTS) when symptoms are clearly present
- Don't omit the retention code if documented—it's clinically significant and affects management
- Document PVR measurements when available to support retention coding and guide treatment decisions 4
- Specify acute vs chronic retention when possible, as this influences both coding specificity and clinical management 6, 3
The combination of N40.1 with a retention code accurately captures both the underlying prostatic pathology and its functional consequence, which is essential for treatment planning—whether medical management with alpha-blockers 7 or consideration for surgical intervention 8.